Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype
- 1 April 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 11 (3) , 247-254
- https://doi.org/10.1097/00008571-200104000-00008
Abstract
Previous studies have shown that patients who present at first or a later presentation with a cluster of new basal cell carcinoma (BCC) comprise a subgroup, termed multiple presentation phenotype (MPP), that is at increased risk of developing further lesions. In this study, we examined the hypothesis that patients who develop multiple clusters are a high-risk subgroup. We found, in a total group of 926 BCC patients, 32 patients with 2–5 BCC clusters (multiple cluster MPP) and 113 cases with only one cluster (single cluster MPP). Multiple cluster MPP cases had mean of 11.3 BCC compared with 3.7 in single cluster MPP cases during similar follow-up. Ultraviolet (UV) exposure in these groups was similar. We determined whether the multiple cluster MPP was associated with characteristics associated with sensitivity to UV or glutathione S-transferase (GST) GSTT1, GSTM1, cytochrome P450 (CYP) CYP2D6, tumour necrosis factor (TNF)-α and vitamin D receptor (VDR) genotypes previously associated with BCC presentational phenotypes. While the frequencies of blue eyes and male gender were greater in multiple cluster than single cluster cases, these differences were not significant. In multiple cluster cases, mean age at first presentation with single tumours occurred earlier and the frequencies of CYP2D6 extensive metabolizer (EM) (94.4%) and GSTT1 null (41.2%) were significantly greater (P = 0.028 and P = 0.004) than in single cluster cases (67.1% and 14.3%, respectively). The odds ratios for the individual associations of CYP2D6 EM and GSTT1 null with the multiple cluster MPP were relatively large; 15.5 and 7.39, respectively. TNF-α and VDR genotypes were not associated with multiple cluster MPP. We propose that the MPP is not the consequence of excessive UV exposure but rather reflects the presence of a distinct BCC subgroup which is defined by combinations of risk genes.Keywords
This publication has 20 references indexed in Scilit:
- Glutathione S-Transferase Polymorphisms and Their Biological ConsequencesPharmacology, 2000
- Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomasBritish Journal of Dermatology, 2000
- Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant lociCarcinogenesis: Integrative Cancer Research, 1999
- Dopamine Formation from Tyramine by CYP2D6Biochemical and Biophysical Research Communications, 1998
- The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties RevealedJournal of Bone and Mineral Research, 1998
- Deficiency of Glutathione S-Transferases T1 and M1 as Heritable Factors of Increased Cutaneous UV Sensitivity.Journal of Investigative Dermatology, 1997
- Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrualCarcinogenesis: Integrative Cancer Research, 1996
- The role of the human homologue of Drosophila patched in sporadic basal cell carcinomasNature Genetics, 1996
- Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumoursThe Lancet, 1994
- The Validity and Practicality of Sun-Reactive Skin Types I Through VIArchives of Dermatology, 1988